Amy Moore, Director of Patient Engagement and Advocacy at Summit Therapeutics, shared a post on LinkedIn:
“It was an honor to interview the one and only Jill Feldman (EGFR Resisters) for a special event in recognition of Lung Cancer Awareness Month today. She shared her story and unique insights borne out of her lived experience with our team. As always, I learn something every time I listen to her. Thank you, Jill!”
More posts featuring Amy C. Moore on OncoDaily.